Oxford Immunotec

Oxford Immunotec announces FDA clearance of the T-SPOT®.TB test for use in pediatrics over the age of two

By Oxford Immunotec
Published: Sept. 29, 2020, 12:42 a.m.· Tags: Diagnostics

The T-SPOT.TB test is now the only interferon-gamma release assay (IGRA) cleared for use in children ages two and upwards in the United States.

France to reimburse IGRAs to screen at-risk individuals for latent TB

By Qiagen, Oxford Immunotec
Published: June 28, 2017, 10:50 p.m.· Tags: Latent TB, Diagnostics

The French decision to reimburse interferon-gamma release assays (IGRAs) for TB screening includes QuantiFERON-TB® Gold Plus (QFT-Plus®) and T-SPOT®.TB Test.

Page 1 of 1 · Total posts: 2

1